Ann: Ceasing to be a substantial holder , page-6

What a croc! What genious would write that "recovery in the share price will be confirmation of a return to growth in sales, recovery in profitability, positive announcements regarding DataTraceDNA and confirmation of success of the commercialisation strategies." What is this - understanding public companies 101? This is the same esoteric BS they've been sprouting for years that is nothing more than baseless rhetoric.

Where's the plan for revenue, who are the new markets, who are the people that are actually going to sell these great products? Where's the detailed sales plan that says how many widgets they expect to sell, by who, to whom, generating what revenue, at what profit margin???

DDT is a basket case; their products disintegrate (or code separate in the case of Trace) in mild conditions; Bottle's track record shows him as an incompetent, bumbling fool with no background in the sector or in marketing or in sales, thay have no sales staff to actually sell, no firm direction and no future.

I got out some time ago; if you stay in you must also believe in the Tooth Fairy and Santa Claus!